Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury

PLoS ONE(2022)10.1371/journal.pone.0264217Source: DataRank Database

17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.96)OA: goldTopics (73)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Evan Werlin ORCID,H Kagaya ORCID,Mian Chen ORCID,Bian Wu ORCID,Giorgio Mottola ORCID

Live enrichment

PubMed:35226675 PMC:PMC8884511 OpenAlex:https://openalex.org/W4214745240

national heart, lung, and blood institute

Grant: HHSN268201400005C

national heart, lung, and blood institute

Grant: HL119508

national institutes of health

Grant: R25 23856

NHLBI NIH HHS

Grant: R01 HL119508

National Institutes of Health

Grant: 4R01HL119508-04

Specialized lipid mediators and mechanisms of resolution in vascular injury

National Institutes of Health

Grant: 3R25EB023856-03S2

R25 Admin Sup, PA-18-680, due date: 05/24/2019; Postdoc: Photiadis

FWCI

0.96

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0264217&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0264217&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0264217

journalhttps://doi.org/10.1371/journal.pone.0264217

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35226675

Fields of Study

Fatty Acid Research and HealthEicosanoids and Hypertension PharmacologySphingolipid Metabolism and Signaling0301 basic medicine03 medical and health sciences0302 clinical medicineAnimalsCarotid ArteriesCell MovementDisease Models, AnimalDocosahexaenoic AcidsHuman Umbilical Vein Endothelial CellsHumansHyperplasiaInflammationMiceNeointimaRAW 264.7 CellsRatsRats, Sprague-DawleyVascular System Injuries

MeSH Terms

RAW 264.7 CellsAnimalsCarotid ArteriesCell MovementDisease Models, AnimalDocosahexaenoic AcidsHumansHyperplasiaInflammationRats, Sprague-DawleyMiceRatsVascular System InjuriesNeointimaHuman Umbilical Vein Endothelial Cells

Keywords

AdventitiaNeointimal hyperplasiaInflammationChemistryPharmacologyMedicineInternal medicineRestenosisDocosahexaenoic AcidsGeneral Science & TechnologyScienceMedical Biotechnology610CardiovascularRats, Sprague-DawleyMiceCell MovementNeointimaHuman Umbilical Vein Endothelial Cells2.1 Biological and endogenous factorsAnimalsHumansAetiologyHyperplasiaBiomedical and Clinical SciencesAnimalQRVascular System InjuriesAtherosclerosisRatsDisease Models, AnimalCarotid ArteriesRAW 264.7 CellsDisease ModelsSprague-DawleyResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being